Replies to post #7659 on GTC Biotherapeutics (fka GTCB)

[keitern]

Dew, regarding the eventual US 35 million Atryn HD sales, what percentage of this will be eaten up by sales expenses either by GTC itself or, presumably, a marketing and sales partner? In other words, what kind of profit margin might we be looking at?